TC
ELV icon

Tavio Capital’s Elevance Health ELV Stock Holding History

Tavio Capital’s Portfolio ELV Stock Details ELV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		– Sell
-104,849
Closed -$29.6M – 15
2019
Q2 		$29.6M Sell
104,849
-56,663
-35% -$15.5M 12.01% 5
2019
Q1 		$46.4M Sell
161,512
-17,264
-10% -$4.99M 17.08% 3
2018
Q4 		$47M Sell
178,776
-1,598
-0.9% -$439K 19.5% 1
2018
Q3 		$49.4M Buy
180,374
+15,842
+10% +$4.11M 19.28% 1
2018
Q2 		$39.2M Sell
164,532
-13,281
-7% -$3.08M 13.26% 2
2018
Q1 		$39.1M Buy
177,813
+43,259
+32% +$10.2M 18.42% 1
2017
Q4 		$30.3M Sell
134,554
-128,610
-49% -$27.4M 16.52% 2
2017
Q3 		$50M Buy
263,164
+23,284
+10% +$4.43M 20.33% 1
2017
Q2 		$45.1M Buy
239,880
+27,758
+13% +$4.99M 22.46% 1
2017
Q1 		$35.1M Buy
+212,122
New +$33.7M 17.95% 2

Other funds holding ELV

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
TCI Fund Management
TCI Fund Management London, United Kingdom $45.2B AUM 12.74% 1-Year Est. Return

Tavio Capital's ELV Position: Q3 2019 in Review

Tavio Capital sold out of Elevance Health (ELV) in Q3 2019, closing a stake of 104,849 shares — an estimated $29.6M sold.

Tavio Capital first reported a position in ELV in Q1 2017 and held it in 10 quarters. The position peaked at $50M in Q3 2017. 1,014 funds tracked by Wall St. Rank hold ELV as of Q3 2019.

  • Tavio Capital reported no remaining Elevance Health position as of Q3 2019 after selling out during the quarter.
  • Tavio Capital sold 104,849 Elevance Health shares in Q3 2019, an estimated $29.6M.
  • Tavio Capital first reported a position in Elevance Health in Q1 2017 and held it in 10 quarters.
  • Tavio Capital's Elevance Health position peaked at $50M in Q3 2017.
  • 1,014 funds tracked by Wall St. Rank held Elevance Health as of Q3 2019.

Based on Tavio Capital's 13F filing for Q3 2019, filed 13 Nov 2019.